Pharmacological research in pediatrics: From neonates to adolescents

被引:52
作者
Rakhmanina, NY
van Den Anker, JN
机构
[1] Childrens Natl Med Ctr, Div Pediat Clin Pharmacol, Washington, DC 20010 USA
[2] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC USA
[3] George Washington Univ, Sch Med & Hlth Sci, Dept Physiol & Pharmacol, Washington, DC USA
[4] Washington Pediat Pharmacol Res Unit, Washington, DC USA
[5] Erasmus MC Sophia Childrens Hosp, Rotterdam, Netherlands
关键词
drug therapy in pediatrics; off-label prescriptions; drug metabolism in pediatrics; phase I enzymes; phase II enzymes;
D O I
10.1016/j.addr.2005.12.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The data guiding the dosing, efficacy and safety of medicines for children have lagged substantially as compared to the information available for adults. As a consequence, pediatricians faced with the prospect of confining their practice to medicines with adequate information have frequently resorted to prescribing medicines for unapproved uses (different dose, frequency, age group, route, indication or formulation). Although a long time in coming, the past decade, have witnessed a new era in drug development for children - an era that is still in its infancy, but which is currently showing signs of maturation. This review will give some of the history and current progress in pharmacological research and pediatric drug development. (c) 2006 Published by Elsevier B.V.
引用
收藏
页码:4 / 14
页数:11
相关论文
共 68 条
[1]   MATURATION OF CAFFEINE ELIMINATION IN INFANCY [J].
ARANDA, JV ;
COLLINGE, JM ;
ZINMAN, R ;
WATTERS, G .
ARCHIVES OF DISEASE IN CHILDHOOD, 1979, 54 (12) :946-949
[2]   DEVELOPMENTAL PATTERNS OF RENAL FUNCTIONAL MATURATION COMPARED IN HUMAN NEONATE [J].
ARANT, BS .
JOURNAL OF PEDIATRICS, 1978, 92 (05) :705-712
[3]  
Bajpai M, 1996, DRUG METAB DISPOS, V24, P1401
[4]   Ontogeny of phase II enzymes: UGT and SULT. [J].
Behm, MO ;
Abdel-Rahman, SM ;
Leeder, JS ;
Kearns, GL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) :P29-P29
[5]   MOLECULAR MECHANISM OF SLOW ACETYLATION OF DRUGS AND CARCINOGENS IN HUMANS [J].
BLUM, M ;
DEMIERRE, A ;
GRANT, DM ;
HEIM, M ;
MEYER, UA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5237-5241
[6]   PARACETAMOL GLUCURONIDATION BY RECOMBINANT RAT AND HUMAN PHENOL UDP-GLUCURONOSYLTRANSFERASES [J].
BOCK, KW ;
FORSTER, A ;
GSCHAIDMEIER, H ;
BRUCK, M ;
MUNZEL, P ;
SCHARECK, W ;
FOURNELGIGLEUX, S ;
BURCHELL, B .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (09) :1809-1814
[7]   THE GENETIC-BASIS OF THE REDUCED EXPRESSION OF BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1 IN GILBERTS-SYNDROME [J].
BOSMA, PJ ;
CHOWDHURY, JR ;
BAKKER, C ;
GANTLA, S ;
DEBOER, A ;
OOSTRA, BA ;
LINDHOUT, D ;
TYTGAT, GNJ ;
JANSEN, PLM ;
ELFERINK, RPJO ;
CHOWDHURY, NR .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) :1171-1175
[8]   PHASE-1 EVALUATION OF ZIDOVUDINE ADMINISTERED TO INFANTS EXPOSED AT BIRTH TO THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BOUCHER, FD ;
MODLIN, JF ;
WELLER, S ;
RUFF, A ;
MIROCHNICK, M ;
PELTON, S ;
WILFERT, C ;
MCKINNEY, R ;
CRAIN, MJ ;
ELKINS, MM ;
BLUM, MR ;
PROBER, CG .
JOURNAL OF PEDIATRICS, 1993, 122 (01) :137-144
[9]   GENTAMICIN INTERVAL IN NEWBORN-INFANTS AS DETERMINED BY RENAL-FUNCTION AND POSTCONCEPTIONAL AGE [J].
BRION, LP ;
FLEISCHMAN, AR ;
SCHWARTZ, GJ .
PEDIATRIC NEPHROLOGY, 1991, 5 (06) :675-679
[10]   DEVELOPMENT OF HUMAN-LIVER UDP-GLUCURONOSYLTRANSFERASES [J].
BURCHELL, B ;
COUGHTRIE, M ;
JACKSON, M ;
HARDING, D ;
FOURNELGIGLEUX, S ;
LEAKEY, J ;
HUME, R .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1989, 13 (2-4) :70-77